protein
| RNA polymerase II associated |
|
interacting with HIV-1Tat and mediating its high affinity to TAR |
|
CDK9 |
|
associates with HEXIM1 to regulate RNA polymerase II elongation of nascent mRNA transcripts (HEXIM1 recognizes the Cyclin T1 subunit, which is a key step toward the regulation of transcription elongation) |
|
BRD4 and HEXIM1 proteins interact with CCNT1 at or very near speckle domain |
|
mechanism of release of CCNT1 and HEXIM1 from the RN7SK snRNP by viral and cellular activators includes a conformational change in RN7SK |
|
transcription of the HIV-1 requires the interaction of CCNT1 subunit of a host cellular factor, with the viral Tat protein at the transactivation response (TAR) element of nascent viral transcripts |
|
mediates the transition from transcription initiation to productive elongation by phosphorylation of the C-terminal domain of RNA polymerase II, and is negatively regulated by the cellular protein HEXIM1 |
|
CDK9 the kinase of CCNT1 stimulates transcription elongation by phosphorylating POLR2A and transcription elongation factors |
|
crucial role for the HEXIM1/CCNT1 pathway in the regulation of satellite cell–mediated muscle regeneration |
|
LARP7 suppresses CCNT1 activity to inhibit breast cancer progression and metastasis |
|
HEXIM1 binds to the CDK9 catalytic site to inhibit CCNT1 |
|
TAT promotes the release of CCNT1 from the 7SK RNP through direct binding to the 7SK RNA |
|
HEXIM1 in addition to its action on CCNT1, plays a role in a variety of different mechanisms: it controls the stability of transcription factor components and assists binding of transcription factors to their targets |
|
MEPCE binds chromatin through the histone H4 tail to serve as a CCNT1 activator at specific genes important for cellular identity |